Are you Dr. Foster?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 77 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
601 N 30th St Ste 2803
Omaha, NE 68131Phone+1 402-280-4100Fax+1 402-552-2512
Summary
- Dr. Jason Foster, MD is a general surgeon in Omaha, Nebraska. He is currently licensed to practice medicine in Nebraska, New York, and Ohio. He is affiliated with Nebraska Medicine - Nebraska Medical Center and is an Associate Professor at University of Nebraska Medical Center College of Medicine.
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Surgery, 1994 - 2002
- Lewis Katz School of Medicine at Temple UniversityClass of 1994
Certifications & Licensure
- NE State Medical License 2005 - 2026
- NY State Medical License 2002 - 2007
- OH State Medical License 1996 - 2005
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow American College of Surgeons
Publications & Presentations
PubMed
- 126 citationsAppendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment.Kim Govaerts, Robin J. Lurvink, I.H.J.T. de Hingh, K. Van der Speeten, Laurent Villeneuve
European Journal of Surgical Oncology. 2021-01-01 - 2 citationsCytoreductive Surgery with HIPEC is a Safe and Effective Palliative Option in Chemorefractory Symptomatic Peritoneal Metastasis.Chunmeng Zhang, Asish Patel, Dalton Hegeholz, Krista Brown, Valerie Shostrom
Annals of Surgical Oncology. 2022-05-01 - 32 citationsThe contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright future.Jason M Foster, Chunmeng Zhang, Shahyan Rehman, Prateek Sharma, H Richard Alexander
CA. 2023-01-01
Press Mentions
- Surgery/HIPEC Safer Than Other High-Risk Cancer ProceduresJanuary 15th, 2019
- Morbidity and Mortality Rates Following Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy Compared with Other High-Risk Surgical Oncology ProceduresJanuary 4th, 2019
Professional Memberships
- Member
- Member
- Member